cladribine has been researched along with Rheumatoid Arthritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konwalinka, G; Mur, E; Pfeiffer, KP; Schirmer, M; Thaler, J | 1 |
| Delannoy, A; Devogelaer, JP; Houssiau, FA | 1 |
| Filippi, M; Rovaris, M; Tortorella, C | 1 |
1 review(s) available for cladribine and Rheumatoid Arthritis
| Article | Year |
|---|---|
Cladribine. Ortho Biotech Inc.
Topics: Adenosine Deaminase Inhibitors; Animals; Antineoplastic Agents; Arthritis, Rheumatoid; Cladribine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Leukemia; Multiple Sclerosis; Structure-Activity Relationship | 2001 |
1 trial(s) available for cladribine and Rheumatoid Arthritis
| Article | Year |
|---|---|
The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trial.
Topics: Aged; Antineoplastic Agents; Arthritis, Rheumatoid; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cladribine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Pilot Projects; Safety | 1997 |
1 other study(ies) available for cladribine and Rheumatoid Arthritis
| Article | Year |
|---|---|
Paradoxical immunologic effects of 2-CdA therapy: comment on the article by Davis et al.
Topics: Anemia, Hemolytic; Antibodies, Antinuclear; Arthritis, Rheumatoid; Cladribine; Female; Humans; Immune System Diseases; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lupus Nephritis; Lymphopenia; Male; Middle Aged | 1998 |